Betamethasone dipropionate/Bexarotene

倍他米松二丙酸酯/贝沙罗汀

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBetamethasone dipropionate/Bexarotene
Drug Alias NameBetamethasone dipropionate+bexarotene倍他米松二丙酸酯+贝沙罗汀Bexarotene/Betamethasone Dipropionate贝沙罗汀+倍他米松二丙酸酯Bexarotene+Betamethasone Dipropionate +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionRetinoid X receptor alpha agonistsRetinoid X receptor gamma agonistsGlucocorticoid receptor agonists +[4] 
TargetsGlucocorticoid receptorRetinoid X receptor gammaRetinoid X receptor alpha +[4] 
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsYes BexaroteneBetamethasone Dipropionate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlmirall Sa
Active IndicationsN/A
Inactive IndicationsPsoriasis

Other Information

ATC CodeN/A
Related LinksN/A